Evidence map›Paper›PMID 34827293›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network.

Lia D'Ambrosio, Rosella Centis, Claudia C Dobler, Simon Tiberi, Alberto Matteelli, Justin Denholm, Dominik Zenner, Seif Al-Abri, Fatma Alyaquobi, Marcos Abdo Arbex and 26 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Active Case Finding for Tuberculosis in Migrants: a Systematic Review.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2024
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Strengthening Tuberculosis Control Among Migrant Workers.Tropical medicine and infectious disease · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Migration and medical screening for tuberculosis.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2023
    Review
  11. Antibiotics and Infectious Respiratory Diseases.Antibiotics (Basel, Switzerland) · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 20 institutions in 16 countries.

Lia D'AmbrosioPublic Health Consulting Group, 6900 Lugano, Switzerland.
Rosella CentisServizio di Epidemiologia, Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, 21049 Tradate, Italy.
Claudia C DoblerThe George Institute for Global Health, University of New South Wales, Sydney, NSW 2042, Australia.ORCID 0000-0002-5460-0189
Simon TiberiDepartment of Infection, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.
Alberto MatteelliDivision of Infectious and Tropical Diseases, Spedali Civili University Hospital, 25123 Brescia, Italy.
Justin DenholmVictorian Tuberculosis Program, Melbourne Health, Melbourne, VIC 3000, Australia.ORCID 0000-0002-9214-6431
Dominik ZennerCentre for Global Public Health, Institute for Population Health Sciences, Queen Mary University, London E1 2AB, UK.
Seif Al-AbriDirectorate General of Disease Surveillance and Control, Ministry of Health, Muscat 100, Oman.ORCID 0000-0002-2669-6814
Fatma AlyaquobiDirectorate General of Disease Surveillance and Control, Ministry of Health, Muscat 100, Oman.
Marcos Abdo ArbexNestor Goulart Reis Hospital, Health Secretary São Paulo State, Sao Paulo 14801-320, Brazil.
Evgeny BelilovskiyMoscow Research and Clinical Center for Tuberculosis Control, 107014 Moscow, Russia.
François-Xavier BlancService de Pneumologie, Centre Hospitalier Universitaire, L'institut du Thorax, F-44093 Nantes, France.ORCID 0000-0001-7644-2188
Sergey BorisovMoscow Research and Clinical Center for Tuberculosis Control, 107014 Moscow, Russia.
Anna Cristina C CarvalhoLaboratório de Inovações em Terapias, Ensino e Bioprodutos (LITEB), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, Brazil.
Jeremiah Muhwa ChakayaDepartment of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi P.O. Box 43844-00100, Kenya.
Nicola CoccoASST Santi Paolo e Carlo-Medicina Penitenziaria, 21100 Milan, Italy.
Luigi Ruffo CodecasaTB Reference Centre, Villa Marelli Institute, Niguarda Hospital, 20159 Milan, Italy.ORCID 0000-0001-6825-2050
Margareth Pretti DalcolmoReference Center Hélio Fraga, Fundação Oswaldo Cruz (Fiocruz), Ministry of Health, Rio de Janeiro 21040-360, Brazil.
Keertan DhedaSouth African MRC Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town 7701, South Africa.
Anh Tuan Dinh-XuanRespiratory Physiology Unit, Department of Respiratory Medicine, Cochin Hospital, Université de Paris, 75014 Paris, France.ORCID 0000-0001-8651-5176
Susanna R EspositoPaediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, 43126 Parma, Italy.
José-María García-GarcíaTuberculosis Research Programme SEPAR, E-08029 Barcelona, Spain.ORCID 0000-0002-2809-6230
Yang LiDepartment of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, China.
Selene MangaMinistry of Health, Direccion General de Gestion de Riesgos en y Desastres en Salud, Lima 15072, Peru.
Valentina MarcheseDivision of Infectious and Tropical Diseases, Spedali Civili University Hospital, 25123 Brescia, Italy.ORCID 0000-0002-5221-1614
Marcela Muñoz TorricoClínica de Tuberculosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.
Emanuele PontaliDepartment of Infectious Diseases, Galliera Hospital, 16128 Genoa, Italy.ORCID 0000-0002-1085-0442
Adrián RendonCentro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias CIPTIR, University Hospital of Monterrey UANL (Universidad Autonoma de Nuevo Leon), Monterrey 64000, Mexico.
Denise Rossato SilvaFaculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-903, Brazil.ORCID 0000-0003-0230-2734
Rupak SinglaDepartment of TB & Respiratory Diseases, National Institute of TB & Respiratory Diseases, Sri Aurobindo Marg, New Delhi 110030, India.
Ivan SolovicNational Institute for TB, Vysne Hagy, Catholic University, 05984 Ruzomberok, Slovakia.
Giovanni SotgiuClinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, 07100 Sassari, Italy.ORCID 0000-0002-1600-4474
Martin van den BoomWHO Regional Office for the Eastern Mediterranean Region, Cairo 11571, Egypt.
Nguyen Viet NhungNational Tuberculosis Programme, Hanoi 100000, Vietnam.
Jean-Pierre ZellwegerTB Competence Center, Swiss Lung Association, 3030 Berne, Switzerland.
Giovanni Battista MiglioriServizio di Epidemiologia, Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, 21049 Tradate, Italy.ORCID 0000-0002-2597-574X
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITCentral Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences · RUIstituti Clinici Scientifici Maugeri · ITMinistry of Health · OMQueen Mary University of London · GBAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITAzienda Socio Sanitaria Territoriale Santi Paolo e CarloCatholic University in Ruzomberok · SKCentro Universitário de Araraquara · BREnte Ospedaliero Ospedali Galliera · ITFudan University · CNFundação Oswaldo Cruz · BRInstitut du Thorax · FRInstituto Nacional de Enfermedades Respiratorias · MXKenyatta University · KELiverpool Hospital · AULRS Institute of Tuberculosis and Respiratory Diseases · INMinistério da Saúde · BRMinistry of Health · PESociedad Española de Neumología y Cirugía Torácica · ES

Funding

World Health Organization 001
6 · The paper itself

Abstract

Tuberculosis (TB) does not respect borders, and migration confounds global TB control and elimination. Systematic screening of immigrants from TB high burden settings and-to a lesser degree TB infection (TBI)-is recommended in most countries with a low incidence of TB. The aim of the study was to evaluate the views of a diverse group of international health professionals on TB management among migrants. Participants expressed their level of agreement using a six-point Likert scale with different statements in an online survey available in English, French, Mandarin, Spanish, Portuguese and Russian. The survey consisted of eight sections, covering TB and TBI screening and treatment in migrants. A total of 1055 respondents from 80 countries and territories participated between November 2019 and April 2020. The largest professional groups were pulmonologists (16.8%), other clinicians (30.4%), and nurses (11.8%). Participants generally supported infection control and TB surveillance established practices (administrative interventions, personal protection, etc.), while they disagreed on how to diagnose and manage both TB and TBI, particularly on which TBI regimens to use and when patients should be hospitalised. The results of this first knowledge, attitude and practice study on TB screening and treatment in migrants will inform public health policy and educational resources.

Indexed as

COVID-19infection controlmigrationpreventionscreeningTBTB infection managementworkplace safety

Identifiers

PMID34827293
PMCPMC8615134
OpenAlexW3214090172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.